| Title: |
Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial) |
| Authors: |
Lecomte, Thierry a, b, ⁎; Giraudeau, Bruno c; Phelip, Jean-Marc d; Tournigand, Christophe e; Ducreux, Michel f; Tougeron, David g; Lepage, Côme h; Mineur, Laurent i; Laplaige, Philippe j; Desgrippes, Romain k; Artru, Pascal l; Borg, Christophe m; Jary, Marine n; Bouché, Olivier o; Metges, Jean-Philippe p; Guimbaud, Rosine q; Aparicio, Thomas r; Foubert, Fanny s; Hautefeuille, Vincent t; Muller, Marie u; Bouhier-Leporrier, Karine v; Darrius, Rémi w; Lobet, Sarah b; Monmousseau, Fanny x; Bejan-Angoulvant, Théodora y, z, aa; Paintaud, Gilles y, z, aa; Ternant, David y, z, aa |
| Source: |
In Digestive and Liver Disease May 2025 57(5):1074-1080 |
| Database: |
ScienceDirect |